Literature DB >> 22108791

Agitated delirium associated with therapeutic doses of sustained-release bupropion.

Diana R Mack1, Liza Barbarello-Andrews, Mei T Liu.   

Abstract

CASE DESCRIPTION: We report a case of a patient initiated on therapeutic doses of sustained-release bupropion for the management of major depressive disorder who subsequently developed acute agitated delirium that required ICU level care. This patient's history was significant for alcohol and cannabis abuse but he was currently detoxified and beyond the withdrawal period. Throughout the course of treatment, all maintenance medications, including bupropion, were discontinued and the patient required escalating doses of benzodiazepines and typical antipsychotics to resolve symptoms. The patient's delirium subsided after approximately 5 days.
CONCLUSION: Dopamine is thought to play a role in the pathophysiology of delirium and given the mechanism of action of this drug and the presence of delirium risk factors in our patient, we are faced with a likely causative factor of this acute delirious episode.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108791     DOI: 10.1007/s11096-011-9587-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  11 in total

1.  Bupropion-induced psychosis.

Authors:  W T Howard; J K Warnock
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

Review 2.  Delirium: optimising management.

Authors:  D J Meagher
Journal:  BMJ       Date:  2001-01-20

3.  Delirium associated with bupropion.

Authors:  T van Putten; I Shaffer
Journal:  J Clin Psychopharmacol       Date:  1990-06       Impact factor: 3.153

Review 4.  The medical management of depression.

Authors:  J John Mann
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

5.  Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.

Authors:  Chia Hsiang Chan; Hsing Cheng Liu; Ming Chyi Huang
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

6.  Psychosis induced by low-dose bupropion: sensitization of dopaminergic system by past cocaine abuse?

Authors:  Margaret Hahn; Tomas Hajek; Martin Alda; Jack M Gorman
Journal:  J Psychiatr Pract       Date:  2007-09       Impact factor: 1.325

7.  Acute psychosis after bupropion treatment in a healthy 28-year-old woman.

Authors:  Justin Bailey; Shannon Waters
Journal:  J Am Board Fam Med       Date:  2008 May-Jun       Impact factor: 2.657

8.  Acute delirium and parkinsonism in a bupropion-treated liver transplant recipient.

Authors:  T B Strouse; S Salehmoghaddam; J E Spar
Journal:  J Clin Psychiatry       Date:  1993-12       Impact factor: 4.384

9.  Acute psychosis after administration of bupropion hydrochloride (Zyban).

Authors:  M Neumann; V Livak; H-W Paul; G Laux
Journal:  Pharmacopsychiatry       Date:  2002-11       Impact factor: 5.788

10.  Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge.

Authors:  Hervé Javelot; Alexandre Baratta; Luisa Weiner; Thierry Javelot; Cathy Nonnenmacher; Jean-Frédéric Westphal; Michaël Messaoudi
Journal:  Pharm World Sci       Date:  2008-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.